曾 進忠

Medicine & Life Sciences

1. Peritoneal Dialysis 100%
2. Pyelonephritis 62%
3. Escherichia coli 62%
4. Peritonitis 49%
5. Kidney 44%
6. Virulence Factors 40%
7. Chronic Renal Insufficiency 37%
8. Microfluidics 30%
9. Peritoneal Fibrosis 30%
10. Community-Acquired Infections 26%
11. Infections 23%
12. Dialysis 21%
13. Urine 21%
14. Uropathogenic Escherichia coli 20%
15. Mortality 19%
16. Macrophage Migration-Inhibitory Factors 18%
17. Point-of-Care Systems 16%
18. Bacteremia 16%
19. Urinary Tract 14%
20. Genes 14%
21. Lab-On-A-Chip Devices 12%
22. Anti-Bacterial Agents 12%
23. University Hospitals 12%
24. Renal Cell Carcinoma 12%
25. Escherichia coli Adhesins 12%
26. Albumins 12%
27. Mass Spectrometry 11%
28. Phosphates 11%
29. Chronic Kidney Failure 11%
30. Catheters 11%
31. Staphylococcus lugdunensis 11%
32. Ureteral Neoplasms 10%
33. Lasers 10%
34. CRISPR-Cas Systems 10%
35. Serum Albumin 10%
36. Virulence 10%
37. Dialysis Solutions 10%
38. Nutrineal 10%
39. Serum 10%
40. Fluoroquinolones 9%
41. sodium phosphate 9%
42. Bacteria 9%